Treatment of peritoneal metastases from gastric carcinoma
By:
References
- 1. Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992, 70(5):1030-1037.
- 2. Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982, 8(1):1-11.
10.1016/0360-3016(82)90377-7 - 3. Fujitani K, Yang HK, Mizusawa J, Kim YW, Terashima M, Han SU et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol 2016, 17(3):309-318.
10.1016/S1470-2045(15)00553-7 - 4. Kerkar SP, Kemp CD, Duffy A, Kammula US, Schrump DS, Kwong KF et al. The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials 2009, 10:121.
- 5. Dai Q, Jiang L, Lin RJ, Wei KK, Gan LL, Deng CH et al. Adjuvant chemoradiotherapy versus chemotherapy for gastric cancer: a meta-analysis of randomized controlled trials. Journal of surgical oncology 2015, 111(3):277-284.
- 6. Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y et al. The 30-year experience-A meta-analysis of randomised and highquality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer 2017, 79:1-14.
10.1016/j.ejca.2017.03.030 - 7. Conlon KC, Karpeh MS, Jr. Laparoscopy and laparoscopic ultrasound in the staging of gastric cancer. Semin Oncol 1996, 23(3):347-351.
- 8. Stell DA, Carter CR, Stewart I, Anderson JR. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg 1996, 83(9):1260-1262.
- 9. Bryan RT, Cruickshank NR, Needham SJ, Moffitt DD, Young JA, Hallissey MT et al. Laparoscopic peritoneal lavage in staging gastric and oesophageal cancer. Eur J Surg Oncol 2001, 27(3):291-297.
10.1053/ejso.2001.1113 - 10. Ribeiro U, Jr., Gama-Rodrigues JJ, Safatle-Ribeiro AV, Bitelman B, Ibrahim RE, Ferreira MB et al. Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 1998, 2(3):244-249.
- 11. Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Annals of surgical oncology 2005, 12(5):347-353.
- 12. Coburn N, Seevaratnam R, Paszat L, Helyer L, Law C, Swallow C et al. Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Annals of surgery 2014, 259(1):102-108.
- 13. Dixon M, Cardoso R, Tinmouth J, Helyer L, Law C, Swallow C et al. What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2014, 17(2):377-382.
10.1007/s10120-013-0262-x - 14. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Annals of surgery 1988, 208(1):36-41.
- 15. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991, 15(4):530-535; discussion 535-536.
10.1007/BF01675656 - 16. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T, Isawa E et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997, 79(5):884-891.
10.1002/(SICI)1097-0142(19970301)79:5<;884::AID-CNCR3>3.0.CO;2-C - 17. Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005, 92(3):370-375.
- 18. Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Annals of surgical oncology 2010, 17(9):2370-2377.
- 19. Yonemura Y, Bandou E, Kinoshita K, Kawamura T, Takahashi S, Endou Y et al. Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am 2003, 12(3):635-648.
10.1016/S1055-3207(03)00035-8 - 20. Canbay E, Mizumoto A, Ichinose M, Ishibashi H, Sako S, Hirano M et al. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Annals of surgical oncology 2014, 21(4):1147-1152.
- 21. Coccolini F, Cotte E, Glehen O, Lotti M, Poiasina E, Catena F et al. Intraperitoneal chemotherapy in advanced gastric cancer. Metaanalysis of randomized trials. Eur J Surg Oncol 2014, 40(1):12-26.
10.1016/j.ejso.2013.10.019 - 22. Brar SS, Mahar AL, Helyer LK, Swallow C, Law C, Paszat L et al. Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel. JAMA surgery 2014, 149(1):18-25.
- 23. Yang X-J, Huang C-Q, Suo T, Mei L-J, Yang G-L, Cheng F-L et al. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial. Annals of surgical oncology 2011, 18(6):1575-1581.
- 24. Yonemura Y. A new bidirectional intraperitoneal and systemic induction chemotherapy (BISIC) for the peritoneal metastasis from gastric cancer in neoadjuvant setting. Integrative Cancer Science and Therapeutics 2014, 1(2):26-29.
- 25. Yonemura Y, Elnemr A, Endou Y, Ishibashi H, Mizumoto A, Miura M et al. Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection. Gastroenterol Res Pract 2012, 2012:521487.
- 26. Mizumoto A, Canbay E, Hirano M, Takao N, Matsuda T, Ichinose M et al. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan. Gastroenterol Res Pract 2012, 2012:836425.
- 27. Roviello F, Caruso S, Neri A, Marrelli D. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Overview and rationale. European Journal of Surgical Oncology (EJSO) 2013, 39(12):1309-1316.
- 28. Glehen O, Passot G, Villeneuve L, Vaudoyer D, Bin-Dorel S, Boschetti G et al. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer 2014, 14(1):183.
10.1186/1471-2407-14-183 - 29. Rau B, Loeffler M, Rau H-G, Sulkowski U, Kuhlmann J, Weimann A, Keck T, Angele M, Topp SA, Koenigsrainer A et al: Perioperative chemotherapy and cytoreductive surgery with versus without HIPEC in gastric cancer with limited peritoneal metastases: A randomized phase III study (GASTRIPEC). Journal of Clinical Oncology 2015, 33(15_suppl):TPS4132-TPS4132.
- 30. Coccolini F, Catena F, Glehen O, Yonemura Y, Sugarbaker PH, Piso P et al. Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis. European Journal of Surgical Oncology (EJSO) 2015, 41(7):911-919.
- 31. Boerner T, Graichen A, Jeiter T, Zemann F, Renner P, Marz L et al. CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer. Annals of surgical oncology 2016, 23(12):3972-3977.
- 32. Esquivel J. Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea. Cancer journal (Sudbury, Mass) 2009, 15(3):249-254.
10.1097/PPO.0b013e3181a58e74 - 33. van der Kaaij RT, Braam HJ, Boot H, Los M, Cats A, Grootscholten C et al. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study. JMIR Res Protoc 2017, 6(7):e136.
- 34. Koh J-L, Yan TD, Glenn D, Morris DL. Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis. Annals of surgical oncology 2009, 16(2):327-333.
- 35. Pfannenberg C, Konigsrainer I, Aschoff P, Oksuz MO, Zieker D, Beckert S et al. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Annals of surgical oncology 2009, 16(5):1295-1303.
- 36. Hong SH, Shin YR, Roh SY, Jeon EK, Song KY, Park CH et al. Treatment outcomes of systemic chemotherapy for peritoneal carcinomatosis arising from gastric cancer with no measurable disease: retrospective analysis from a single center. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2013, 16(3):290-300.
10.1007/s10120-012-0182-1 - 37. Valle M, Federici O, Garofalo A. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment. Surg Oncol Clin N Am 2012, 21(4):515-531.
10.1016/j.soc.2012.07.005 - 38. Nath J, Moorthy K, Taniere P, Hallissey M, Alderson D. Peritoneal lavage cytology in patients with oesophagogastric adenocarcinoma. Br J Surg 2008, 95(6):721-726.
- 39. Lee SD, Ryu KW, Eom BW, Lee JH, Kook MC, Kim YW. Prognostic significance of peritoneal washing cytology in patients with gastric cancer. Br J Surg 2012, 99(3):397-403.
- 40. Lisiecki R, Spychala A, Pater K, Murawa D. Analysis Of Risk Factors Of Positive Peritoneal Cytology In Patients Treated For Gastric Cancer-Preliminary Report. Polski przeglad chirurgiczny 2015, 87(10):506-512.
- 41. Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y et al. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999, 178(3):256-262.
- 42. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 1994, 14(5B):2131-2134.
- 43. Fujiwara Y, Doki Y, Taniguchi H, Sohma I, Takiguchi S, Miyata H et al. Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2007, 10(4):197-204.
10.1007/s10120-007-0436-5 - 44. Huang JY, Xu YY, Sun Z, Zhu Z, Song YX, Guo PT et al. Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Asian Pac J Cancer Prev 2012, 13(9):4379-4385.
- 45. Sun J, Song Y, Wang Z, Gao P, Chen X, Xu Y et al. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer 2012, 12:526.
10.1186/1471-2407-12-526 - 46. Mi DH, Li Z, Yang KH, Cao N, Lethaby A, Tian JH et al. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials. Int J Hyperthermia 2013, 29(2):156-167.
- 47. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G et al. A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer. Annals of surgical oncology 2007, 14(10):2702-2713.
- 48. Braam HJ, Schellens JH, Boot H, van Sandick JW, Knibbe CA, Boerma D et al. Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer. Critical Reviews in Oncology/Hematology 2015, 95(3):282-296.
- 49. Scaringi S, Kianmanesh R, Sabate JM, Facchiano E, Jouet P, Coffin B et al. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. Eur J Surg Oncol 2008, 34(11):1246-1252.
10.1016/j.ejso.2007.12.003 - 50. Coccolini F, Celotti A, Ceresoli M, Montori G, Marini M, Catena F et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) and neoadjuvant chemotherapy as prophylaxis of peritoneal carcinosis from advanced gastric cancer-effects on overall and disease free survival. J Gastrointest Oncol 2016, 7(4):523-529.
- 51. Yonemura Y, Canbay E, Li Y, Coccolini F, Glehen O, Sugarbaker PH et al. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. European Journal of Surgical Oncology (EJSO) 2016, 42(8):1123-1131.
- 52. Yonemura Y, Ishibashi H, Hirano M, Mizumoto A, Takeshita K, Noguchi K et al. Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Neoadjuvant Intraperitoneal/Systemic Chemotherapy on Peritoneal Metastases from Gastric Cancer. Annals of surgical oncology 2017, 24(2):478-485.
Language: English
Page range: 173 - 179
Submitted on: Dec 22, 2017
Accepted on: Dec 29, 2017
Published on: Mar 9, 2018
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2018 Wojciech P. Polkowski, Karol Rawicz-Pruszynski, Jerzy Mielko, Katarzyna Geca, Magdalena Skorzewska, Bogumila Cisel, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.